{"title":"丙戊酸钠处方新指南","authors":"Sue Thomas","doi":"10.12968/bjnn.2024.20.sup1a.s24","DOIUrl":null,"url":null,"abstract":"At the end of November 2023, the Medicines and Healthcare products Regulatory Agency published a UK-wide National Patient Safety Alert relating to the use of sodium valproate in men and women with epilepsy. Sue Thomas outlines the rationale for this and the implications for nurses who are caring for patients who might be taking this medication.","PeriodicalId":505118,"journal":{"name":"British Journal of Neuroscience Nursing","volume":"70 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New guidance on sodium valproate prescribing\",\"authors\":\"Sue Thomas\",\"doi\":\"10.12968/bjnn.2024.20.sup1a.s24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"At the end of November 2023, the Medicines and Healthcare products Regulatory Agency published a UK-wide National Patient Safety Alert relating to the use of sodium valproate in men and women with epilepsy. Sue Thomas outlines the rationale for this and the implications for nurses who are caring for patients who might be taking this medication.\",\"PeriodicalId\":505118,\"journal\":{\"name\":\"British Journal of Neuroscience Nursing\",\"volume\":\"70 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Neuroscience Nursing\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12968/bjnn.2024.20.sup1a.s24\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Neuroscience Nursing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12968/bjnn.2024.20.sup1a.s24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
At the end of November 2023, the Medicines and Healthcare products Regulatory Agency published a UK-wide National Patient Safety Alert relating to the use of sodium valproate in men and women with epilepsy. Sue Thomas outlines the rationale for this and the implications for nurses who are caring for patients who might be taking this medication.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
